782 results on '"Sargos, P"'
Search Results
2. A mean-value theorem for exponential sums. Applications to Weyl's inequality
3. Stereotactic body radiation therapy after radical prostatectomy: current status and future directions
4. Deep radiomic signature with immune cell markers predicts the survival of glioma patients
5. Emergency radiation therapy in modern-day practice: Now or never, or never again ?
6. PARP inhibitors in prostate cancers, is it time for combinations?
7. What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
8. Is trimodal therapy the current standard for muscle-invasive bladder cancer?
9. Terapia trimodal para el cáncer de vejiga: ¿es ahora el estándar para la enfermedad músculo-invasiva?
10. Approaches to Oligometastatic Renal Cell Carcinoma
11. Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches
12. Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer
13. The role of radiation therapy for de novo metastatic bladder and renal cancers
14. Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?
15. Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
16. Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis
17. Chromogranin A: a useful biomarker in castration-resistant prostate cancer
18. How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?
19. Détection précoce du cancer de la prostate : vers un nouveau paradigme ?
20. Les grands principes des traitements du cancer de prostate localisé
21. Relations entre doses dans les structures anatomiques et dysfonction érectile après radiothérapie pour un cancer de la prostate : revue systématique de la littérature
22. Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens
23. Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer Network
24. Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
25. Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
26. How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position
27. Management of patients with a persistently elevated PSA after radical prostatectomy: a narrative review
28. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease
29. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance
30. Stratégie de préservation vésicale basée sur le traitement trimodal : quelle place dans la prise en charge du carcinome infiltrant de la vessie ?
31. Avancées récentes dans la prise en charge du cancer de la prostate localisé à haut risque : mise au point par le Comité Prostate de l’Association française d’urologie
32. Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic)
33. Recherche d’altérations des gènes de réparation de l’ADN dans le cancer de la prostate : mise au point pratique du Comité de cancérologie de l’association française d’urologie
34. Conformal radiotherapy in management of soft tissue sarcoma in adults
35. External radiotherapy for prostatic cancers
36. A 5-Year Contemporary Nationwide Evolution of the Radical Prostatectomy Landscape
37. A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
38. Radiothérapie de rattrapage après prostatectomie radicale : que faire en cas de concentration de PSA postopératoire élevée persistante ou de récidive locale macroscopique ?
39. Terapia trimodal: ¿el nuevo tratamiento estándar para el tumor vesical músculo-inavasor?
40. A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
41. Postoperative radiotherapy in prostate cancer: Dose and volumes
42. Radiothérapie postopératoire des cancers de la prostate : à quel moment la proposer ? Quelle place pour la déprivation androgènique ?
43. Place de la radiothérapie dans la prise en charge des sarcomes
44. Nouveautés dans la chirurgie des cancers de la prostate localisés de haut risque
45. Editorial: Post Operative Radiation Treatment for Prostate Cancer
46. Same-day-discharge Robot-assisted Radical Prostatectomy: An Annual Countrywide Analysis
47. Adjuvant and Neoadjuvant Radiation Therapy for Locally Advanced Bladder Cancer
48. What is the Optimal Dose, Fractionation and Volume for Bladder Radiotherapy?
49. Résultats dosimétriques et cliniques d’une stratégie de radiothérapie adaptativede type “bibliothèque de plans” des cancers de la vessie localisés
50. Radiothérapie adaptative des cancers de la vessie : état de l’art et perspectives pratiques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.